Home Cart 0 Sign in  
X

[ CAS No. 179321-49-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 179321-49-4
Chemical Structure| 179321-49-4
Chemical Structure| 179321-49-4
Structure of 179321-49-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 179321-49-4 ]

Related Doc. of [ 179321-49-4 ]

Alternatived Products of [ 179321-49-4 ]

Product Details of [ 179321-49-4 ]

CAS No. :179321-49-4 MDL No. :MFCD00798168
Formula : C11H19NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :WYVFPGFWUKBXPZ-UHFFFAOYSA-N
M.W : 213.27 Pubchem ID :1512535
Synonyms :

Calculated chemistry of [ 179321-49-4 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.82
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 57.59
TPSA : 55.4 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.78 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.23
Log Po/w (XLOGP3) : 1.16
Log Po/w (WLOGP) : 2.02
Log Po/w (MLOGP) : 1.05
Log Po/w (SILICOS-IT) : 1.46
Consensus Log Po/w : 1.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.63
Solubility : 5.01 mg/ml ; 0.0235 mol/l
Class : Very soluble
Log S (Ali) : -1.92
Solubility : 2.57 mg/ml ; 0.0121 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.16
Solubility : 1.46 mg/ml ; 0.00685 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.13

Safety of [ 179321-49-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 179321-49-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 179321-49-4 ]
  • Downstream synthetic route of [ 179321-49-4 ]

[ 179321-49-4 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 179321-49-4 ]
  • [ 84060-08-2 ]
Reference: [1] Patent: WO2008/21375, 2008, A2, . Location in patent: Page/Page column 42-43
  • 2
  • [ 224309-64-2 ]
  • [ 179321-49-4 ]
YieldReaction ConditionsOperation in experiment
87%
Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -60℃; for 1.25 h;
Stage #2: With triethylamine In dichloromethane at -60 - 20℃;
A methylene chloride solution (6 ml) of dimethyl sulfoxide (2.0 ml, 28.2 mmol) was added dropwise to a methylene chloride solution (30 ml) of oxalyl chloride (1.7 ml, 19.5 mmol) at -60°C over a period of 10 minutes and stirred at -60°C for another 10 minutes. Then, a methylene chloride solution (140 ml) of tert-butyl 4-hydroxycyclohexylcarbamate (2.56 g, 11.9 mmol) was added dropwise thereto over a period of 35 minutes, and the resulting mixture was stirred at -60°C for 40 minutes. After triethylamine (8.4 ml, 60.3 mmol) was added thereto at -60°C, the resulting mixture was warmed up to room temperature spontaneously. Water was added to the reaction mixture, followed by extraction with chloroform. The organic layer was washed with a saturated aqueous ammonium chloride solution and a saturated aqueous sodium chloride solution and then dried over magnesium sulfate. The solvent was distilled off under reduced pressure and the resulting residue was purified by a silica gel column chromatography (eluent: chloroform/ethyl acetate) to obtain tert-butyl 4-oxocyclohexylcarbamate (2.23 g, 87percent).1H-NMR (DMSO-d6): 1.06-1.20 (4H, m), 1.35 (9H, s), 1.69-1.76 (4H, m), 3.12-3.31 (2H, m), 4.48 (1H, s), 6.64 (1H, d, J=7.5Hz).
85.7% With pyridinium chlorochromate In chloroform at 0 - 20℃; for 3 h; Step-2,
Synthesis of tert-butyl (4-oxocyclohexyl)carbamate:
A solution of tert-butyl (4-oxocyclohexyl) carbamate (5g, 0.0232 mol) in chloroform (50ml_) was cooled to 0 °C and pyridiniumchlorochromate (12.49g, 0.058mol) was added portion wise. After addition completed the resulting mixture was allowed to RT and stirred for 3 h. The reaction mixture was diluted with chloroform (100ml_) and washed with brine, water, dried over sodium sulphate and evaporated under vacuum. The residue was purified by column chromatography on silica gel (5percent MeOH-DCM) to afford tert-butyl (4-oxocyclohexyl)carbamate of 4.2g, 85.7percent yield.1HNMR (CDCI3, 300MHz): δ 4.5 (m, 1 H), 3.91 (m, 1 H), 2.4(m, 4H), 2.2 (m, 2H), 1.6 (m, 2H), 1 .45 (m, 9H).
82.1% With Dess-Martin periodane In dichloromethane at 20℃; Cooling with ice Dess-Martin oxidizer (29.0 g, 68.3 mmol) was added dropwise to a solution of N-4-Boc-aminocyclohexanol (9.8 g, 45.52 mmol) in dichloromethane (200 mL) with ice-bath stirring. Warm to room temperature and stir the reaction mixture overnight. The mixture was carefully quenched with a saturated aqueous solution of sodium thiosulfate in an ice bath and extracted three times with dichloromethane. The combined organic phases were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo. Column chromatography on a silica gel column yielded 4-oxo. Tert-butyl cyclohexylcarbamate (7.96 g, yield 82.1percent).
7 g With Dess-Martin periodane In dichloromethane at 20℃; To a solution of tert- v y\ 4-hydroxy- cyclohexylcarbamate (10.0 g, 46.5 mmol) in DCM (100 mL) was added Dess-Martin periodinane (39.4 g, 92.9 mmol) portionwise. The resulting solution was stirred at r.t. overnight and treated with aq. Na2S203 solution and extracted with DCM (3 x 100 mL). The combined organic layers were washed with water (2 x 100 mL) and brine (100 mL), dried over anhydrous Na2SC>4, and concentrated. The residue was purified by column chromatography on silica gel using petroleum ether / EtOAc (V:V, 10: 1) to afford desired product as a white solid (7.0 g, 70percent crude yield).

Reference: [1] Patent: EP1403255, 2004, A1, . Location in patent: Page 71
[2] Medicinal Chemistry Research, 2013, vol. 22, # 6, p. 2633 - 2644
[3] Patent: WO2015/22664, 2015, A1, . Location in patent: Paragraph 00219;00220
[4] Patent: TW2017/36341, 2017, A, . Location in patent: Paragraph 0489-0491
[5] Patent: WO2005/21515, 2005, A2, . Location in patent: Page/Page column 72-73
[6] Patent: WO2013/107291, 2013, A1, . Location in patent: Page/Page column 64
[7] Patent: WO2013/107405, 2013, A1, . Location in patent: Page/Page column 49
[8] Patent: WO2015/10626, 2015, A1, . Location in patent: Page/Page column 64; 65
[9] Patent: WO2015/10297, 2015, A1, . Location in patent: Page/Page column 64
  • 3
  • [ 111300-06-2 ]
  • [ 179321-49-4 ]
YieldReaction ConditionsOperation in experiment
20.5 g
Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 1 h; Inert atmosphere
Stage #2: With triethylamine In dichloromethane at -78 - 20℃; for 3 h; Inert atmosphere
The oxalyl chloride (11.8 mL, 0.14 mol) was dissolved in methylene chloride (100 mL) and then cooled to -78 ° C. Under nitrogen, To a solution of dimethylsulfoxide diluted in methylene chloride (100 mL) Im-1c-a (20 g, 0.093 mol) diluted in dichloromethane (19.8 mL, 0.28 mol) and methylene chloride (300 mL) were added dropwise. Methylene chloride (300 mL) was further added to the reaction mixture, and the mixture was stirred for 1 hour. Triethylamine (64.7 mL, 0.46 mol) was added dropwise and stirred for 1 hour. The reaction mixture was stirred for 2 hours while slowly raising the temperature to room temperature, and distilled water (100 mL) was added to terminate the reaction. The reaction mixture was extracted with methylene chloride. The organic layer was washed with distilled water and saturated brine, dried over anhydrous sodium sulfate, concentrated, and n-hexane was added to the residue to obtain a solid. The resulting solid was filtered and washed with n-hexane to give the title compound im-1c-b as a pale brown solid (20.5 g).
Reference: [1] Heterocycles, 2002, vol. 58, p. 471 - 504
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 12, p. 3103 - 3107
[3] Patent: KR101798840, 2017, B1, . Location in patent: Paragraph 0270-0271; 0276-0277
  • 4
  • [ 224309-64-2 ]
  • [ 114615-82-6 ]
  • [ 7529-22-8 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: US2004/19058, 2004, A1,
  • 5
  • [ 114615-82-6 ]
  • [ 24424-99-5 ]
  • [ 27489-62-9 ]
  • [ 50910-54-8 ]
  • [ 7529-22-8 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: US2004/19058, 2004, A1,
  • 6
  • [ 224309-64-2 ]
  • [ 87413-09-0 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: US2015/87600, 2015, A1, . Location in patent: Page/Page column
[2] Patent: US2013/190249, 2013, A1, . Location in patent: Page/Page column
[3] Patent: US2015/31627, 2015, A1, . Location in patent: Page/Page column
  • 7
  • [ 224309-64-2 ]
  • [ 79-37-8 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: US5574044, 1996, A,
  • 8
  • [ 24424-99-5 ]
  • [ 179321-49-4 ]
Reference: [1] Heterocycles, 2002, vol. 58, p. 471 - 504
[2] Patent: WO2013/107291, 2013, A1,
[3] Patent: WO2015/10297, 2015, A1,
[4] Patent: WO2013/107405, 2013, A1,
[5] Patent: WO2015/10626, 2015, A1,
[6] Medicinal Chemistry Research, 2013, vol. 22, # 6, p. 2633 - 2644
[7] Patent: WO2015/22664, 2015, A1,
[8] Patent: KR101798840, 2017, B1,
  • 9
  • [ 6850-65-3 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: US2013/190249, 2013, A1,
[2] Patent: WO2013/107291, 2013, A1,
[3] Patent: WO2015/10297, 2015, A1,
[4] Patent: WO2013/107405, 2013, A1,
[5] Patent: WO2015/10626, 2015, A1,
[6] Patent: US2015/31627, 2015, A1,
[7] Patent: US2015/87600, 2015, A1,
  • 10
  • [ 27489-62-9 ]
  • [ 179321-49-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 12, p. 3103 - 3107
[2] Angewandte Chemie - International Edition, 2014, vol. 53, # 12, p. 3236 - 3240[3] Angew. Chem., 2014, vol. 126, # 12, p. 3300 - 3304,5
[4] Patent: KR101798840, 2017, B1,
  • 11
  • [ 24424-99-5 ]
  • [ 179321-49-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2014, vol. 53, # 12, p. 3236 - 3240[2] Angew. Chem., 2014, vol. 126, # 12, p. 3300 - 3304,5
  • 12
  • [ 24424-99-5 ]
  • [ 27489-62-9 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: EP1500643, 2005, A1,
  • 13
  • [ 50910-54-8 ]
  • [ 179321-49-4 ]
Reference: [1] Heterocycles, 2002, vol. 58, p. 471 - 504
  • 14
  • [ 34619-03-9 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: EP1403255, 2004, A1,
  • 15
  • [ 27489-62-9 ]
  • [ 179321-49-4 ]
Reference: [1] Patent: EP1403255, 2004, A1,
  • 16
  • [ 179321-49-4 ]
  • [ 675112-67-1 ]
YieldReaction ConditionsOperation in experiment
93% With diethylamino-sulfur trifluoride In dichloromethane for 15 h; To a solution of 1, 1-dimethylethyl (4-oxocyclohexyl) carbamate (1 g, 4.69 MMOL, 1 equiv) in CH2CI2 (15 ml) was added DAST (1.05 MI, 7.98 mmol, 1.7 equiv) and the resulting mixture was stirred for 15 h. A saturated aqueous NAHC03 solution was added and the resulting biphasic mixture was stirred vigorously for 1 h. The two layers were separated and the aqueous phase extracted with CH2CI2. The combined organic phase were dried over MGS04 and concentrated in vacuo to give 1, 1-dimethylethyl (4, 4-difluorocyclohexyl) carbamate (D277) (1.03 g, 93percent) as a beige solid which was used in the next step without further purification.
56%
Stage #1: With diethylamino-sulfur trifluoride In dichloromethane at -5 - 20℃; Inert atmosphere
Stage #2: With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 0 - 20℃;
Stage #3: at 0 - 20℃;
To a solution of tert-butyl 4-oxocyclo- hexylcarbamate (2.13 g, 10 mmol) in dry DCM (25 mL) was added DAST (2.58 g, 16 mmol) dropwise at -5 °C under nitrogen protection. After addition, the reaction mixture was stirred at r.t overnight. The reaction mixture was poured into ice water slowly and extracted by DCM ( 3 x 100 mL). The combined organic layers were washed with 2 N aq. NaHC03 and brine, dried over anhydrous Na2SC>4, filtered and concentrated in vacuum. The residue was purified by column chromatography using petroleum ether / EtOAc (V: V, 5: 1) as eluent to afford a mixture of the title compound (-70percent) and the byproduct tert-butyl 4-fluorocyclohex-3-enylcarbamate (-30percent) as a light-yellow solid.
54.7%
Stage #1: With diethylamino-sulfur trifluoride In dichloromethane at 20℃; Cooling with ice
Stage #2: With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 5 - 20℃; Cooling with ice
Stage #3: With sodium tetrahydroborate In methanol at 20℃; Cooling with ice
Step B: tert-butyl (4,4-difluorocyclohexyl)carbamateDiethylaminosulfur trifluoride (8.54 g, 52.981 mmol) was added dropwise to the methylene chloride containing tert-butyl 4-oxocyclohexylcarbamate (7.96 g, 37.323 mmol) while stirring in an ice salt bath. In a (200 mL) solution, slowly warm to room temperature and stir the reaction mixture overnight. The mixture was carefully quenched with saturated aqueous ammonium chloride under an ice bath and extracted three times with dichloromethane. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated in vacuo.Separation of tert-butyl (4,4-difluorocyclohexyl)carbamate by column chromatography (about 70percent)With tert-butyl 4-fluorocyclohexyl-3-enylcarboxylate (about 30percent).Under ice-cooling, m-CPBA (6.9 g, 40.0 mmol) was slowly added dropwise to the methylene chloride solution of the above mixture while keeping the system temperature below 5°C. After completion of the dropwise addition, the mixture was warmed to room temperature and stirred overnight. Quench with saturated aqueous sodium thiosulfate under an ice bath and stir at room temperature for half an hour, extract three times with methylene chloride, wash the combined organic phases with brine, dry over sodium sulfate, filter, and concentrate in vacuo, directly without purification. Used for the next step.The above concentrated residue was dissolved in methanol, and sodium borohydride (630 mg, 16.662 mmol) was added in small portions in an ice bath. The reaction mixture was warmed to room temperature and stirred overnight. The solvent was concentrated in vacuo, methanol, and quenched with water under an ice bath. The mixture was quenched with stirring at room temperature for half an hour. Ethyl acetate was extracted three times. The combined organic phases were washed with brine and dried over sodium sulfate. Filtration and concentration in vacuo gave tert-butyl (4,4-difluorocyclohexyl)carbamate (4.8 g, 54.7percent yield).
43% With diethylamino-sulfur trifluoride In dichloromethane at 20℃; for 16 h; To a solution of 1, 1-dimethylethyl (4-oxocyclohexyl) carbamate (3.56 g, 16.7 MMOL, 1 equiv) in CH2CI2 (50 mi) was added DAST (4.6 MI, 35.1 mmol, 2.1 equiv) and the resulting mixture was stirred at room temperature for 16 h. A saturated aqueous NAHC03 solution (20 mi) was added and the biphasic mixture was vigorously stirred at room temperature for 1 h. The layers were separated and the aqueous phase extracted with CH2CI2. The combined organic layers were dried over MGS04 and concentrated in vacuo. Trituration of the residue with hexane gave 1, 1-dimethylethyl (4,4- difluorocyclohexyl) carbamate (D52) (1.7 g, 43percent) as a white solid which was used in the next step without further purification.

Reference: [1] Patent: WO2004/50619, 2004, A1, . Location in patent: Page 71
[2] Patent: WO2013/107405, 2013, A1, . Location in patent: Page/Page column 49-50
[3] Patent: TW2017/36341, 2017, A, . Location in patent: Paragraph 0489; 0492-0495
[4] Patent: WO2004/94430, 2004, A1, . Location in patent: Page 27
[5] Patent: WO2004/111033, 2004, A1, . Location in patent: Page 24; 25
[6] Patent: WO2004/112793, 2004, A1, . Location in patent: Page/Page column 154
[7] Patent: US2004/19049, 2004, A1,
[8] Patent: WO2007/127704, 2007, A1, . Location in patent: Page/Page column 40
[9] Patent: WO2003/99818, 2003, A1, . Location in patent: Page 95-96
[10] Patent: WO2013/107291, 2013, A1, . Location in patent: Page/Page column 64; 65
[11] Patent: WO2015/10626, 2015, A1, . Location in patent: Page/Page column 64; 65; 66
[12] Patent: WO2015/10297, 2015, A1, . Location in patent: Page/Page column 64-65
  • 17
  • [ 179321-49-4 ]
  • [ 675112-67-1 ]
  • [ 675112-69-3 ]
YieldReaction ConditionsOperation in experiment
70% With diethylamino-sulfur trifluoride In dichloromethane at -5 - 20℃; Inert atmosphere Step C: Tert-butyl 4,4-difluorocyclohexylcarbamate. To a solution of /3 and brine, dried over anhydrous Na2S04, filtered and concentrated in vacuo. The residue was purified by column chromatography using petroleum ether / EtOAc (V:V, 5: 1) as eluent to afford a mixture of the title compound (-70percent) and the byproduct tert-butyl 4-fluorocyclohex-3-enylcarbamate (-30percent) as a light-yellow solid.
Reference: [1] Patent: WO2013/107291, 2013, A1, . Location in patent: Page/Page column 64
[2] Patent: WO2004/24728, 2004, A2, . Location in patent: Page 112
[3] Journal of Organic Chemistry, 2010, vol. 75, # 10, p. 3401 - 3411
[4] Patent: WO2013/107405, 2013, A1, . Location in patent: Page/Page column 49-50
[5] Patent: WO2015/10297, 2015, A1, . Location in patent: Page/Page column 64
  • 18
  • [ 179321-49-4 ]
  • [ 675112-67-1 ]
YieldReaction ConditionsOperation in experiment
70% With diethylamino-sulfur trifluoride In dichloromethane at 20℃; Cooling with ice Step B: tert-butyl (4,4-difluorocyclohexyl)carbamateDiethylaminosulfur trifluoride (8.54 g, 52.981 mmol) was added dropwise to the methylene chloride containing tert-butyl 4-oxocyclohexylcarbamate (7.96 g, 37.323 mmol) while stirring in an ice salt bath. In a (200 mL) solution, slowly warm to room temperature and stir the reaction mixture overnight. The mixture was carefully quenched with saturated aqueous ammonium chloride under an ice bath and extracted three times with dichloromethane. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated in vacuo.Separation of tert-butyl (4,4-difluorocyclohexyl)carbamate by column chromatography (about 70percent)With tert-butyl 4-fluorocyclohexyl-3-enylcarboxylate (about 30percent).Under ice-cooling, m-CPBA (6.9 g, 40.0 mmol) was slowly added dropwise to the methylene chloride solution of the above mixture while keeping the system temperature below 5°C. After completion of the dropwise addition, the mixture was warmed to room temperature and stirred overnight. Quench with saturated aqueous sodium thiosulfate under an ice bath and stir at room temperature for half an hour, extract three times with methylene chloride, wash the combined organic phases with brine, dry over sodium sulfate, filter, and concentrate in vacuo, directly without purification. Used for the next step.The above concentrated residue was dissolved in methanol, and sodium borohydride (630 mg, 16.662 mmol) was added in small portions in an ice bath. The reaction mixture was warmed to room temperature and stirred overnight. The solvent was concentrated in vacuo, methanol, and quenched with water under an ice bath. The mixture was quenched with stirring at room temperature for half an hour. Ethyl acetate was extracted three times. The combined organic phases were washed with brine and dried over sodium sulfate. Filtration and concentration in vacuo gave tert-butyl (4,4-difluorocyclohexyl)carbamate (4.8 g, 54.7percent yield).
Reference: [1] Patent: TW2017/36341, 2017, A, . Location in patent: Paragraph 0489; 0492; 0493
  • 19
  • [ 675112-69-3 ]
  • [ 179321-49-4 ]
  • [ 675112-67-1 ]
Reference: [1] Patent: US2013/190249, 2013, A1, . Location in patent: Page/Page column
[2] Patent: US2015/31627, 2015, A1, . Location in patent: Page/Page column
[3] Patent: US2015/87600, 2015, A1, . Location in patent: Page/Page column
  • 20
  • [ 179321-49-4 ]
  • [ 675112-70-6 ]
Reference: [1] Patent: US2015/87600, 2015, A1,
[2] Patent: TW2017/36341, 2017, A,
[3] Patent: TW2017/36341, 2017, A,
  • 21
  • [ 179321-49-4 ]
  • [ 233764-32-4 ]
Reference: [1] Patent: WO2011/6074, 2011, A1,
[2] Patent: WO2013/96744, 2013, A1,
[3] Patent: EP3072893, 2016, A1,
  • 22
  • [ 179321-49-4 ]
  • [ 917342-29-1 ]
Reference: [1] Patent: CN106543039, 2017, A,
[2] Patent: CN106543039, 2017, A,
  • 23
  • [ 179321-49-4 ]
  • [ 1379295-90-5 ]
Reference: [1] Patent: WO2012/29070, 2012, A1,
  • 24
  • [ 179321-49-4 ]
  • [ 1251009-79-6 ]
Reference: [1] Patent: WO2012/29070, 2012, A1,
Same Skeleton Products
Historical Records